Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.45 USD | -0.55% | +9.66% | -30.04% |
14/05 | Transcript : Syros Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
14/05 | Syros Pharmaceuticals, Inc. Agrees to Amend Its Loan Agreement with Oxford Finance LLC | CI |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
15Cr | - | - | - | |||
4.21TCr | ||||||
4.2TCr | ||||||
2.92TCr | ||||||
2.6TCr | ||||||
1.89TCr | - |